These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 19637188)
1. Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3. Giugliano S; Oezkan F; Bedrejowski M; Kudla M; Reiser M; Viazov S; Scherbaum N; Roggendorf M; Timm J Hepatology; 2009 Sep; 50(3):707-16. PubMed ID: 19637188 [TBL] [Abstract][Full Text] [Related]
2. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C. López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760 [TBL] [Abstract][Full Text] [Related]
3. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073. Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999 [TBL] [Abstract][Full Text] [Related]
4. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing. Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603 [TBL] [Abstract][Full Text] [Related]
5. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen. Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525 [TBL] [Abstract][Full Text] [Related]
6. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection. López-Labrador FX; He XS; Berenguer M; Cheung RC; Wright TL; Greenberg HB J Immunol Methods; 2004 Apr; 287(1-2):91-9. PubMed ID: 15099758 [TBL] [Abstract][Full Text] [Related]
8. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells. Ziegler S; Skibbe K; Walker A; Ke X; Heinemann FM; Heinold A; Mok JY; van Esch WJ; Yang D; Wölfl M; Timm J J Virol; 2014 Oct; 88(19):11080-90. PubMed ID: 25008925 [TBL] [Abstract][Full Text] [Related]
9. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977 [TBL] [Abstract][Full Text] [Related]
10. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain. Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961 [TBL] [Abstract][Full Text] [Related]
11. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596 [TBL] [Abstract][Full Text] [Related]
12. Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses. Zhang S; Bakshi RK; Suneetha PV; Fytili P; Antunes DA; Vieira GF; Jacobs R; Klade CS; Manns MP; Kraft AR; Wedemeyer H; Schlaphoff V; Cornberg M J Virol; 2015 Aug; 89(16):8304-17. PubMed ID: 26041301 [TBL] [Abstract][Full Text] [Related]
13. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection. Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers. Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644 [TBL] [Abstract][Full Text] [Related]
15. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. Nelson DR; Marousis CG; Davis GL; Rice CM; Wong J; Houghton M; Lau JY J Immunol; 1997 Feb; 158(3):1473-81. PubMed ID: 9013994 [TBL] [Abstract][Full Text] [Related]
17. Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus. Pfafferott K; Deshpande P; McKinnon E; Merani S; Lucas A; Heckerman D; Mallal S; John M; Gaudieri S; Lucas M PLoS One; 2015; 10(6):e0130420. PubMed ID: 26107956 [TBL] [Abstract][Full Text] [Related]
18. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation. Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468 [TBL] [Abstract][Full Text] [Related]
19. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection. Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108 [TBL] [Abstract][Full Text] [Related]
20. Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A*02:01 allele. Antunes DA; Rigo MM; Silva JP; Cibulski SP; Sinigaglia M; Chies JA; Vieira GF Mol Immunol; 2011 Jul; 48(12-13):1461-7. PubMed ID: 21513985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]